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1. Introduction 
~ate~hol~~e hormone st~~iation of the turkey 
erythrocyte adenylate cyclase involves a /3-adrenergic 
receptor, probably associated with a guanyl nucleo- 
tide binding protein, a catecholamine-sensitive gua- 
nosine t~phosphat~~ (GTFase) and an adenylate 
cycfase catalytic unit [ 1,2 J_ The ~de~t~~g of the 
intricate regulatory mechanisms which modulate the 
activities of these 4 different components, requires an 
analytical appraach involving the sequential solubili- 
zation and purification of each functional unit. 
We have described [3,4] the solub~~zation a d phy- 
sical separation of the turkey erythrocyte padrenergic 
receptor from the adenylate cyclase catalytic com- 
ponent. A 20 OOO-fold purification of a pharmacoIog& 
cal active receptor was achieved by affinity chromato- 
graphy 1% 
We now report the solub~zation of the catechol- 
amine sensitive GTPase from the same membrane 
preparations. 
2. Materials and methods 
Turkey erythrocyte plasma membranes were pre- 
pared by the method in [6] with the modifications in 
IS]. An av. 50 mg membrane protein was obtained 
from 100 mi blood. Membranes were stored for 
many months without loss of biological activities. 
2 2. Pretredmen t of membranes 
Turkey erythrocyte membranes were incubated 
for 20 min at 37°C with or without 50 &M (-)- 
epinephrine plus 100 #M GMF f7]_ The ~cubation 
medium contained 2mM MgGl?, 1 mM EGTA, 90 mM 
NaCl and 10 mM Tris-HCl (pH 7.4) (incubation 
buffer) and membrane protein at 5 mg/ml. At the end 
of the incubation, membranes were centrifuged at 
30 000 X g for 10 mm at 4’C and washed twice with 
incubation buffer. The membranes obtained after 
removal of the supe~at~t were either used for the 
assays or solubilized. 
Membranes were suspended in 2 mM MgCla 1 mM 
EGTA, 90 mM NaCl, 250 mM sucrose and IO mM 
Tris-HCl (pH 7.4) and treated with digitonin as in 
[S]. After centrifugation at 30 000 X g for 30 min at 
4”C!, the supematant constituted the solubilized pre- 
paration. This cent~fugation procedure was routinely 
used since ~tra~nt~fugation at 105 000 X g for 
60 min did not sediment additional material. 
2.4. Assays 
Adenylate cyclase ATP pyrophosphat~-lya~ 
(~y~~~~g) (EC 4.6.1.1) activity was determined as in 
[S]. Cyclic AMP was isolated and measured as in [S J* 
GTPase activity was measured as in [2 1, except 
that the assays contsined -10 E.cg protein. The specific 
GTPase was calculated by subtracting from the total 
GTP hydrolysis, the non-specific GTP hydrolysis 
estimated in the presence of an excess (20 PM) of 
unlabeled GTP. 
Protein determinations were done as in [9] using 
bovine serum albumin as standard. 
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3. Results and discussion Table 2 
Turkey erythrocyte membranes contain GTPase 
[2,5] and adenylate cyclase [4], both stimulated by 
catecholamine hormones. Solubilization of the plasma 
membranes by the use of digitonin results in the loss 
of GTPase sensitivity to catecholamines and of adeny- 
late cyclase sensitivity to catecholamines and to Gpp- 
(NH)p. However, pretreatment of the membranes 
with (-)epinephrine and GMP, followed by digitonin 
solubilization, results in a soluble sensitive GTPase 
which remains in the supernatant even after centri- 
fugation at 105 000 X g: (-)epinephrine amplifies the 
enzymic activity by 78%. Pretreatment with either 
(-)epinephrine or GMP alone has no effect (table 1). 
Effects of padrenergic agents on GTPase activity in 
pretreated erythrocyte membranes 
Addition 
None 
(-)-Epinephrine 
(-)-Norepinephrine 
(-)-Isoproterenol 
(-)-Propranolol 
(+)-Epinephrine 
(+)-Isoproterenol 
(+Alprenolol 
GTPase 
activity 
35.4 
64.6 
65.7 
67.6 
30.8 
35.2 
34.0 
37.5 
Intact membranes do not require pretreatment with 
GMP and (-)epinephrlne to display a catecholamine 
sensitive GTPase (table 1): the epinephrine stimula- 
tion is not affected by pretreatment of the membranes 
and equals that observed in solubilized membranes. It 
should be noted that solubilization procedures result 
in a partial purification of GTPase: digitonin extracts 
53% of the enzyme activity but only 18% of total 
membrane protein, thus providing a 3-fold increase in 
specific activity (table 1). Other agonists, uch as (-)- 
norepinephrine and (-)-isoproterenol, also stimulate 
the soluble GTPase, whereas the corresponding (t)- 
isomers and the antagonists, (-)-propranolol and (-)- 
alprenolol, do not (table 2). 
Membranes were pretreated with 100 rM GMP and 50 PM 
(-)epinephrine for 20 mm at 37°C. GTPase activities were 
determined in the absence (basal) or in the presence of 
100 r.~cM ligand (except 200 PM (+)-alprenolol). Activities are 
expressed in pmol “Pi liberated . 10 mm-’ . mg protein-‘. 
Values are means from 3 determinations 
Digitonin-solubilized xtracts from epinephrine 
and GMP pretreated membranes also contain adenylate 
cyclase which is stimulated by Gpp(NH)p but is not 
responsive to epinephrine (fig.1). This result agrees 
with that found in [7] in Lubrol PX solubilized 
extracts from pigeon erythrocyte membranes. Pre- 
treatment by GMP and (-)epinephrine uncovers the 
GTP-induced ecrease of agonist binding affinity of 
the turkey erythrocyte /3-adrenergic receptor. These 
% increase caused 
by the ligand 
82 
86 
91 
- 
0 
_ 
6 
Table 1 
Influence of membrane pretreatment on the catecholamlne stimulated GTPase 
activity in membranes and in digitonin extracts from turkey erythrocyte membranes 
Membranes pretreated 
with 
GTPase activity 
Membranes 
Basal Catecholamine 
stimulated 
Digitonm extracts 
Basal Catecholamine 
stimulated 
Buffer 17.1 30.7 (79%) 50.5 45.9 
GMP and (-)-Epinephrine 14.1 24.7 (75%) 41.9 14.5 (79%) 
GMP - - 44.5 50.5 (13%) 
(-)-Epinephrine - - 46.2 48.3 (5%) 
Membranes (5 mg/ml) were pretreated with 100 r.rM GMP and/or 50 MM (-)epine- 
phrine for 20 mm at 37°C and washed twice. GTPase activities were determined, 
according to [2] with modifications [5], on membranes (11 pg membrane protein/ 
assay) and on digitonin solubllized membranes (8 Irg protein/assay), in the absence 
(basal) and in the presence of 100 PM (-)epinephrine (catecholamine stimulated). 
Activities are expressed ln pmol “Pi liberated . 10 min-’ . mg protein-‘. Results 
are means from 3 determinations. The values in parentheses refer to the % stimu- 
lation by eplnephrlne of the GTPase activity 
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Fig.1. Adenylate cyclase activity in digitonin-solubilized 
extracts from GMP and epmephrine pretreated turkey ery- 
throcyte membranes. Membranes (5 mg/ml) were pretreated 
with 100 crM GMP and 50 PM (-)epinephrine for 20 mm at 
37”C, washed twice and solubilized by digitonin 0.25% 
(W/V). Adenylate cyclase activities were measured in the 
absence (basal) or in the presence of 100 PM (-)epinephrine 
or 100 IBM Gpp(NH)p or (-)epinephrine plus Gpp(NH)p. 
Activities are expressed in pmol/cAMP produced . 20 min-’ . 
mg protein-‘. Values are means from 3 determinations. 
findings were interpreted as removal by GMP and 
hormone of endogenously bound inhibitory forms of 
guanine nucleotides [7,10,11]. We here show that 
pretreatment of membranes with GMP and (-)-epine- 
phrine apparently stabilizes, during digitonin solubi- 
lization, the catecholamine s nsitivity of the turkey 
erythrocyte membrane GTPase. This stabilization 
may be explained by association i solution of the 
receptor and the GTPase. 
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